Alpha Tau Medical Ltd (DRTS) vs Inhibrx Biosciences Inc. (INBX)
A side-by-side comparison of Alpha Tau Medical Ltd and Inhibrx Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DRTS
Alpha Tau Medical Ltd
$14.44HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
INBX
Inhibrx Biosciences Inc.
$96.77HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — DRTS vs INBX
growth of $100 · dividends reinvested · last 6yDRTS +47.4% (+6.7%/yr)INBX +277.1% (+24.8%/yr)INBX compounded faster over this window
DRTS INBX
DRTS vs INBX: by the numbers
- •INBX is the larger company ($1.42B vs $1.30B market cap).
- •Both run net losses; DRTS's is the smaller (0.00% vs -10773.46% net margin).
Metrics side by side
Valuation
| Metric | DRTS | INBX |
|---|---|---|
| P/B ratio | 29.60 | N/A |
Profitability
| Metric | DRTS | INBX |
|---|---|---|
| Gross margin | 0.00% | -91.00% |
| Operating margin | 0.00% | -10386.54% |
| Net margin | 0.00% | -10773.46% |
| ROE | -210.13% | N/A |
| ROIC | -40.47% | -99.35% |
Growth (annualized)
| Metric | DRTS | INBX |
|---|---|---|
| Total return CAGR (5Y) | 8.59% | 27.64% |
Frequently asked
- How have DRTS and INBX total returns compared?
- Over the past 5 years, DRTS delivered 8.59% and INBX delivered 27.64% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.